|
Laxman Pai, Opalesque Asia: Venture capital investment in the Americas remained steady in Q2'20 - reaching $35.6 billion over 2,354 deals, said a study.
According to a report by KPMG, this represents more than half the total raised worldwide. Global venture capital investment showed continued resilience in the second quarter of 2020, reaching $62.9 billion across 4,502 deals.
the 10 largest deals in the region all took place in the US, including a $3 billion raised by Waymo, a $850 million raised by Stripe, a $700 million raised by Samsara, and a $500 million raised by Palantir Technologies.
Investments in the US spanned numerous sectors, including automotive, fintech, agriculture, drug discovery, biotech, and application software.
While many VC investors in the US focused on managing the needs of companies within their existing portfolios during Q2'20, they also showed interest in companies with highly relevant, scalable business models aligned to meeting the needs of consumers and businesses within the `new normal' --particularly companies focused on B2B productivity, cybersecurity, digital services, and e-commerce.
Life sciences and biotech solutions garnered significant attention from VC investors in the US during Q2'20, led by cancer screening company Grail's $390 million raise and drug developer Erasca's $200 million deal. While these sectors had already been on the radar of VC investors in recent quarters, the pandemic ha...................... To view our full article Click here
|